Neimeth (NEIMETH)

Currency in NGN
7.65
+0.20(+2.68%)
Closed·
NEIMETH Scorecard
Full Analysis
Net income is expected to grow this year
NEIMETH is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
7.507.65
52 wk Range
1.7610.42
Key Statistics
Bid/Ask
7.46 / 8.10
Prev. Close
7.45
Open
7.45
Day's Range
7.5-7.65
52 wk Range
1.76-10.42
Volume
2.03M
Average Volume (3m)
5.04M
1-Year Change
328.16%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NEIMETH Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
3.32
Downside
-56.60%
Members' Sentiments
Bearish
Bullish
ProTips
Stock has taken a big hit over the last week

Neimeth News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Neimeth Company Profile

Neimeth International Pharmaceuticals Plc manufactures and markets pharmaceutical and animal health products in Nigeria and Ghana. It provides health care, ethical, and veterinary related products; and poultry and animal range of anthelmintic products, as well as production enhancing medicaments. The company was formerly known as Pfizer Inc. and changed its name to Neimeth International Pharmaceuticals Plc. In 1997. Neimeth International Pharmaceuticals Plc was incorporated in 1957 and is based in Lagos, Nigeria.

Employees
196
Market
Nigeria

Compare NEIMETH to Peers and Sector

Metrics to compare
NEIMETH
Peers
Sector
Relationship
P/E Ratio
−37.6x−0.1x−0.5x
PEG Ratio
−0.880.020.00
Price/Book
18.0x1.6x2.6x
Price / LTM Sales
6.3x1.0x3.2x
Upside (Analyst Target)
−58.3%33.6%44.1%
Fair Value Upside
Unlock18.0%6.2%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 3.32
(-56.60% Downside)

Earnings

Latest Release
May 05, 2025
EPS / Forecast
0.03 / --
Revenue / Forecast
1.21B / --
EPS Revisions
Last 90 days

NEIMETH Income Statement

People Also Watch

17.500
CWG
+2.94%
4.90
UPDC
+3.16%
20.000
NEM
0.00%
700.41
GS
-0.79%
2.40
WAPIC
-4.00%

FAQ

What Stock Exchange Does Neimeth Trade On?

Neimeth is listed and trades on the Lagos stock exchange.

What Is the Stock Symbol for Neimeth?

The stock symbol for Neimeth is "NEIMETH."

What Is the Neimeth Market Cap?

As of today, Neimeth market cap is 32.90B.

What Is Neimeth's Earnings Per Share (TTM)?

The Neimeth EPS (TTM) is -0.20.

From a Technical Analysis Perspective, Is NEIMETH a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Neimeth Stock Split?

Neimeth has split 6 times.

How Many Employees Does Neimeth Have?

Neimeth has 196 employees.

What is the current trading status of Neimeth (NEIMETH)?

As of 22 Jul 2025, Neimeth (NEIMETH) is trading at a price of 7.65, with a previous close of 7.45. The stock has fluctuated within a day range of 7.50 to 7.65, while its 52-week range spans from 1.76 to 10.42.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.